Keyphrases
Glioblastoma
100%
Glioma
70%
Tumor
36%
Brain Tumor
31%
5-Aminolevulinic Acid (5-ALA)
22%
Human Glioblastoma
22%
Neuro-oncology
17%
Tumor Heterogeneity
17%
Core Outcome Set
16%
High-grade Glioma
16%
Overall Survival
16%
Resection
16%
Glioma Patients
15%
Brain Cancer
15%
Cucurbits
15%
COVID-19
15%
Drug Delivery Vehicle
15%
After Surgery
15%
Patient-derived Xenograft
15%
Evolutionary Dynamics
15%
Platform Studies
15%
Multiparametric MRI (mpMRI)
15%
Intraoperative Magnetic Resonance Imaging (iMRI)
14%
Primary Brain Tumor
14%
Extent of Resection
14%
Surgeons
13%
Clinical Trials
12%
Central Nervous System Tumors
12%
Circulating Tumor DNA (ctDNA)
12%
Adult Patients
12%
Neurosurgical Oncology
11%
Temozolomide
10%
Cell Behavior
10%
Help-seeking
10%
Coronavirus Disease (COVID)
10%
Length of Stay
10%
Oncology Service
10%
Patient Management
9%
Drug Combination
9%
Health-related Quality of Life
9%
Copy number Variation
9%
Genome Analysis
9%
United Kingdom
9%
Tumor Evolution
9%
Glioma Model
9%
Cerebrospinal Fluid
9%
Primary Glioma
9%
Soft Materials
9%
Surgical Resection
9%
Reconfiguration
9%
Medicine and Dentistry
Ganglioglioma
95%
Glioblastoma
76%
Neoplasm
70%
Intracranial Tumor
39%
Magnetic Resonance Imaging
27%
Diseases
26%
Aminolevulinic Acid
24%
Systematic Review
18%
Neuro-Oncology
17%
Xenograft
15%
Drug Delivery Vehicle
15%
COVID-19
15%
Neurosurgery
15%
Quality of Life
14%
Overall Survival
13%
Neurosurgical Oncology
12%
Carmustine
12%
Surgeon
11%
Brain Cancer
10%
Circulating Tumor DNA
9%
Central Nervous System
9%
Decision Making
9%
Cerebrospinal Fluid
9%
Observational Study
9%
Intraoperative MRI
9%
Progression Free Survival
8%
Retrospective Cohort Study
8%
Health Care Cost
8%
Cell-Free DNA
7%
Restylane
7%
Multiparametric Magnetic Resonance Imaging
7%
External Ventricular Drain
7%
Cohort Analysis
7%
Cytometry
7%
Brain Tissue
7%
Diabetes Insipidus
7%
Outcome Assessment
7%
Patient Experience
7%
Glioblastoma Cell Line
7%
Quality Improvement
7%
Meningioma
7%
Quality of Life Measure
7%
Adjuvant Chemotherapy
7%
Oligoastrocytoma
7%
Immunoglobulin Producing Cell
7%
Isocitrate Dehydrogenase
7%
Ex Vivo
7%
Stem Cell
7%
Tumor of Central Nervous System
7%
Minimal Residual Disease
7%